Pay in 4 interest-free payments of $6.31 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Glucagon-Like Peptide 1 Receptor Agonists and the Eye AT A GLANCE Glucagon-like peptide 1 receptor agonists (GLP-1RA) are FDA-approved for treating type 2 diabetes and are commonly used in weight loss regimens
Common side effects include nausea, vomiting, diarrhoea, and constipation consistent with the known GLP-1 receptor agonist class profile
Lin CJ, DeRoo LA, Jacobs SR, Sandler DP
Side effects are similar to those seen in diabetes patients, mostly mild and gastrointestinal
From the lab to patients: a systematic review and meta-analysis of mesenchymal stem cell therapy for stroke
US$ 24.49
US$ 20.35
US$ 20.21
